Global Payout, Inc. this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., successfully hosted a joint networking event last week in Las Vegas with fellow companies operating in the cannabis financial market sector.
Global Payout, Inc. this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., successfully hosted a joint networking event last week in Las Vegas with fellow companies operating in the cannabis financial market sector.
As it gets set to become the world's first legal recreational marijuana market, Canada is gearing up to be the main exporter for pot worldwide.
InMed Pharmaceuticals is a turnaround stock, with recent news updates showing promise for future gains
InMed Pharmaceuticals develops technology to bridge the gap between synthetic and natural cannabinoids.
New cannabinoid medicine can be successfully administered via a topical gel lens into the eye, a new InMed-University of British Columbia study reports.
Marijuana Company of America (OTC: MCOA) is a distinctive corporation utilizing a strategic business structure within this burgeoning industry.
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Specialized holding company SinglePoint, Inc. (OTC: SING) is the focus of a newly-released podcast interview announced this morning by Investorideas.com.
Looking at how the expertise of InMed's management, consulting and advisory team combines to drive value for shareholders.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., is currently in the process of ramping-up its sales and marketing efforts within Los Angeles County for its newly-acquired PotSaver brand.
7,700 kg per annum facility to focus on high-margin concentrates, leveraging award-winning MPX brand.
We think that InMed’s proprietary technology could put $6.6 Billion in play and make it one of the strongest biotech stocks in the market. We also think InMed is in the right place at the right time to create real value for investors in the Industry. Here's a few reasons why.
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
India Globalization Capital, Inc. (NYSE American: IGC) this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH.
ChineseInvestors.com continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the CBD health products market.